Publication: The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
Date
2016-06-01T00:00:00Z
Authors
Ozcelik, M.
Odabas, H.
Ercelep, O.
Yuksel, S.
Mert, A. G.
Aydin, D.
Surmeli, H.
Isik, D.
Isik, S.
Oyman, A.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The optimal treatment in older persons with metastatic colorectal cancer (mCRC) is complicated by a lack of general agreement. The aim of this study was to evaluate the activity of bevacizumab plus capecitabine combination in elderly mCRC patients who were not suitable for chemotherapy with irinotecan and oxaliplatin-containing regimens.
Description
Keywords
Citation
Ozcelik M., Odabas H., Ercelep O., Yuksel S., Mert A. G. , Aydin D., Surmeli H., Isik D., Isik S., Oyman A., et al., -The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients-, CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.18, ss.617-624, 2016